cost-effectiveness research

Research Reports

Community Oncologists‚ Perception and Adaptability to Emerging Chimeric Antigen T-Cell Therapy

10/16/2017

Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...

...

10/16/2017

Journal of Clinical Pathways

Research in Review

Distress Screening Adherence Results in Less Medical Resource Utilization, Cost Savings

07/25/2017

JCP Editors

Adherence to distress screening protocols could lead to 18% fewer ER visits and 19% fewer hospitalizations, according to a recent study published in Journal of the National Comprehensive Cancer Network (July...

...

07/25/2017

Journal of Clinical Pathways

Research in Review

Biomarker Screening Pathway Aids Diagnosis of Monogenic Diabetes

07/18/2017

JCP Editors

A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients, according to results of a population-based assessment published in Diabetes...

A...

07/18/2017

Journal of Clinical Pathways

Research in Review

Decreasing TKI Dosage Provides Better Outcomes in CML, Lowers Costs

06/29/2017

JCP Editors

Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...

...

06/29/2017

Journal of Clinical Pathways

Research in Review

Insulin Pump Therapy Inferior to Insulin Injections in Cost-Effectiveness

06/23/2017

JCP Editors

Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...

...

06/23/2017

Journal of Clinical Pathways

Research in Review

Navigation Program Lowers Costs for Older Survivors of Cancer

06/20/2017

JCP Editors

A lay navigation program for older survivors of cancer can reduce hospitalizations, emergency department (ED) visits, and intensive care unit admissions, resulting in lower health care costs. ----- Related...

A lay...

06/20/2017

Journal of Clinical Pathways

Clinical Pathways for Advance Stage Gastric Cancer: Standardizing Practice to Decrease Variability and Improve Outcomes

06/13/2017

EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...

...

06/13/2017

Journal of Clinical Pathways

Research in Review

Biologic Therapy Not Cost-Effective in Patients With RA

06/13/2017

JCP Editors

A cost-effectiveness analysis showed that patients with rheumatoid arthritis (RA) who switch from a disease-modifying antirheumatic drug (DMARD) to a biologic drug are likely to increase costs of care while receiving...

A...

06/13/2017

Journal of Clinical Pathways

Research in Review

Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing

05/31/2017

JCP Editors

Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...

Women...

05/31/2017

Journal of Clinical Pathways

Department

Colon Cancer Costs Continue Rising

03/15/2017

JCP Editors

The cost of colon cancer care rose significantly during the period from 2003 to 2013, despite decreases in overall hospitalizations and lengths of stay. ----- Related Content Adjuvant Chemotherapy Improves Colon...

The...

03/15/2017

Journal of Clinical Pathways